Study analysis · European journal of radiology · 2020
Marathon runners have less dangerous heart plaque—but 1 in 6 still have dangerous artery blockages.
Hardcore runners have softer, less dangerous heart gunk than couch potatoes, but their arteries can still get clogged.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study found that athletes had less dangerous plaque in their heart arteries than non-athletes, but it didn’t randomly assign people to be athletes or not — so we can’t say exercise caused the difference. It just shows they’re linked.
What’s the bottom line?
Runners who train a lot have less dangerous types of heart plaque and their arteries open wider with a special medicine, but they still might have narrow arteries.
How strong is this study?
The study used fancy heart scans to measure things carefully, but since it looked back at who was already an athlete, it might be missing other reasons why athletes have healthier hearts — like better diets or less stress. So we can’t fully trust that exercise alone is the reason.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
29 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=100)+7.9/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. Randomization not stated; study is retrospective and observational. Cannot establish causation.
Key takeaways
- 01
17.3% of runners had artery narrowing ≥50%; runners had less non-calcified plaque (p<0.001); nitroglycerin made their artery volume bigger (21.1 vs 14.8) but only in runners.
- 02
Yes — even though runners have less dangerous plaque, nearly 1 in 5 still had significant artery narrowing, which could be risky.
Surprising findings
- Endurance athletes had significantly better vasodilatory response to nitroglycerin (V/M ratio 21.1 vs. 14.8) than sedentary individuals, who showed no such difference.It’s counterintuitive that a drug’s effect would be stronger in athletes—most assume their arteries are already 'optimized' and wouldn’t respond more. This suggests training enhances vascular reactivity beyond just plaque reduction.
Practical takeaways
If you're an endurance athlete, consider a coronary CTA if you have symptoms or family history—your plaque may be less dangerous, but blockages can still occur.
This was an observational study with no full text available; causation cannot be proven, and methodology details (blinding, randomization) are unknown.
low confidenceWhy this study matters
Runners Have Less Dangerous Plaque
Endurance athletes had significantly lower non-calcified plaque burden (SIS p=0.003, G-score p<0.001) and fewer high-risk plaques (p<0.001) compared to sedentary individuals. These plaque types are more likely to rupture and cause heart attacks.
People assume exercise prevents all heart plaque—but this shows it specifically reduces the most dangerous kind, even if it doesn’t eliminate all risk.
Nitroglycerin Works Better in Athletes
When given nitroglycerin, athletes showed a 21.1 V/M ratio vs. 14.8 in athletes who didn’t get it (p<0.001)—but sedentary people showed no difference. This suggests their arteries respond more dynamically to vasodilators.
It implies endurance training might improve how arteries 'breathe' under stress—not just reduce plaque, but make them more flexible and responsive.
Calcified Plaque Is Just as Common
Despite less dangerous plaque, athletes had no significant difference in coronary artery calcium score (CACS) compared to sedentary people (p=0.055). This means hard, calcified plaque builds up just as much.
It flips the script: exercise doesn’t stop calcification—it just changes the type. Calcified plaque is stable, but still a sign of long-term heart stress.
17.3% of Athletes Had Severe Blockages
Nearly 1 in 6 endurance athletes (17.3%) had coronary stenosis ≥50%, a level that often requires medical intervention—even though they were healthier in other ways.
This shatters the myth that elite exercise = perfect heart health. Even the fittest aren’t immune to serious blockages.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Runners who train a lot have less dangerous types of heart plaque and their arteries open wider with a special medicine, but they still might have narrow arteries.
Research results
17.3% of runners had artery narrowing ≥50%; runners had less non-calcified plaque (p<0.001); nitroglycerin made their artery volume bigger (21.1 vs 14.8) but only in runners.
What this means - more context
Yes — even though runners have less dangerous plaque, nearly 1 in 5 still had significant artery narrowing, which could be risky.
To assess the effect of endurance exercise on coronary vasodilatory capacity and atherosclerosis using coronary CTA and CFD modeling.
Endurance athletes had lower non-calcified plaque burden (SIS, G-score) and fewer high-risk plaques than sedentary individuals, with no difference in CACS. Athletes receiving nitroglycerin showed higher V/M ratio than those who did not, a difference absent in sedentary controls. Coronary stenosis ≥50% was present in 17.3% of athletes.
Methods Used
Retrospectively matched cohort study of 100 subjects (age 56.2±11, 29 females); endurance athletes (≥1h/unit, ≥3x/week) compared to sedentary controls; coronary CTA with CFD analysis including CADRADS, SIS, G-score, CACS, FFRCT, V/M ratio.
Main Finding
Endurance athletes had lower non-calcified plaque burden (SIS p=0.003, G-score p<0.001), fewer high-risk plaques (p<0.001), no difference in CACS (p=0.055), and higher V/M ratio with nitroglycerin (21.1 vs. 14.8, p<0.001) only in athletes.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Retrospective design with unknown randomization and blinding
- •No effect sizes or confidence intervals reported for key outcomes
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Endurance athletes had significantly better vasodilatory response to nitroglycerin (V/M ratio 21.1 vs. 14.8) than sedentary individuals, who showed no such difference.
It’s counterintuitive that a drug’s effect would be stronger in athletes—most assume their arteries are already 'optimized' and wouldn’t respond more. This suggests training enhances vascular reactivity beyond just plaque reduction.
Practical Takeaways
If you're an endurance athlete, consider a coronary CTA if you have symptoms or family history—your plaque may be less dangerous, but blockages can still occur.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Lower probability
on the GRADE evidence scale
This study found that athletes had less dangerous plaque in their heart arteries than non-athletes, but it didn’t randomly assign people to be athletes or not — so we can’t say exercise caused the difference. It just shows they’re linked.
Strengths
- Uses objective imaging measures (CTA, CFD, FFRCT)
- Includes matched control group
- Quantitative plaque and hemodynamic metrics reported
Weaknesses
- Full methodology not available - based on abstract only
- Randomization: Unknown → treated as non-randomized
- Blinding: Unknown → cannot assume outcome assessors were blinded
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Runners who train a lot have less dangerous types of heart plaque and their arteries open wider with a special medicine, but they still might have narrow arteries.
Research results
17.3% of runners had artery narrowing ≥50%; runners had less non-calcified plaque (p<0.001); nitroglycerin made their artery volume bigger (21.1 vs 14.8) but only in runners.
What this means - more context
Yes — even though runners have less dangerous plaque, nearly 1 in 5 still had significant artery narrowing, which could be risky.
To assess the effect of endurance exercise on coronary vasodilatory capacity and atherosclerosis using coronary CTA and CFD modeling.
Endurance athletes had lower non-calcified plaque burden (SIS, G-score) and fewer high-risk plaques than sedentary individuals, with no difference in CACS. Athletes receiving nitroglycerin showed higher V/M ratio than those who did not, a difference absent in sedentary controls. Coronary stenosis ≥50% was present in 17.3% of athletes.
Methods Used
Retrospectively matched cohort study of 100 subjects (age 56.2±11, 29 females); endurance athletes (≥1h/unit, ≥3x/week) compared to sedentary controls; coronary CTA with CFD analysis including CADRADS, SIS, G-score, CACS, FFRCT, V/M ratio.
Main Finding
Endurance athletes had lower non-calcified plaque burden (SIS p=0.003, G-score p<0.001), fewer high-risk plaques (p<0.001), no difference in CACS (p=0.055), and higher V/M ratio with nitroglycerin (21.1 vs. 14.8, p<0.001) only in athletes.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Retrospective design with unknown randomization and blinding
- •No effect sizes or confidence intervals reported for key outcomes
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Endurance athletes had significantly better vasodilatory response to nitroglycerin (V/M ratio 21.1 vs. 14.8) than sedentary individuals, who showed no such difference.
It’s counterintuitive that a drug’s effect would be stronger in athletes—most assume their arteries are already 'optimized' and wouldn’t respond more. This suggests training enhances vascular reactivity beyond just plaque reduction.
Practical Takeaways
If you're an endurance athlete, consider a coronary CTA if you have symptoms or family history—your plaque may be less dangerous, but blockages can still occur.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Lower probability
on the GRADE evidence scale
This study found that athletes had less dangerous plaque in their heart arteries than non-athletes, but it didn’t randomly assign people to be athletes or not — so we can’t say exercise caused the difference. It just shows they’re linked.
Strengths
- Uses objective imaging measures (CTA, CFD, FFRCT)
- Includes matched control group
- Quantitative plaque and hemodynamic metrics reported
Weaknesses
- Full methodology not available - based on abstract only
- Randomization: Unknown → treated as non-randomized
- Blinding: Unknown → cannot assume outcome assessors were blinded
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study used fancy heart scans to measure things carefully, but since it looked back at who was already an athlete, it might be missing other reasons why athletes have healthier hearts — like better diets or less stress. So we can’t fully trust that exercise alone is the reason.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
29 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=100)+7.9/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. Randomization not stated; study is retrospective and observational. Cannot establish causation.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Conflicting evidence
Evidence points in both directions — no clear conclusion yet.
Evidence
Authored by
17 researchersIf this is your work, this is how we attribute it on Fit Body Science. Gudrun Maria Feuchtner is listed as the lead author.